Jefferies Financial Group’s AstraZeneca AZN Stock Holding History

Jefferies Financial Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,000	Closed	-$4.24M	–	1594
2024 Q3	$4.24M	Buy	+20,000	New	+$3.23M	0.03%	355
2023 Q3	–	Sell	-39,500	Closed	-$5.65M	–	1616
2023 Q2	$5.65M	Sell	39,500 -64,200	-62%	-$9.45M	0.05%	328
2023 Q1	$14.4M	Buy	103,700 +81,200	+361%	+$10.9M	0.12%	149
2022 Q4	$3.05M	Buy	+22,500	New	+$2.82M	0.02%	515

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Jefferies Financial Group's AZN Position: Q1 2026 in Review

Jefferies Financial Group increased its AstraZeneca (AZN) stake by 271% in Q1 2026, buying an estimated $2.08M and bringing the position to 14,788 shares worth $2.88M. The position accounts for 0.02% of the portfolio, ranked #491.

Jefferies Financial Group first reported a position in AZN in Q4 2022 and has held it in 9 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Jefferies Financial Group held 14,788 shares of AstraZeneca worth $2.88M as of Q1 2026.
Jefferies Financial Group bought 10,800 AstraZeneca shares in Q1 2026, an estimated $2.08M.
AstraZeneca made up 0.02% of Jefferies Financial Group's portfolio in Q1 2026, its #491 holding.
Jefferies Financial Group first reported a position in AstraZeneca in Q4 2022 and has held it in 9 quarters since.
1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.